Tetraphase Pharmaceuticals, Inc. (TTPH) has seen some recent action in the market and its stock were last quoted at $2.1900 on friday. Investors are starting to take interest of TTPH as the stock traded as high as $2.5300 and as low as $1.9600 in the previous trading day.
Tetraphase Pharmaceuticals, Inc. (TTPH) average trading volume is 1.16M. However, in the previous trading day Tetraphase Pharmaceuticals, Inc. (TTPH) traded 10,863,126 shares. The 1st support level on TTPH is $2.08 and the 1st resistance level on TTPH is $3.84. TTPH 50 day moving average is $1.4065 and TTPH 200day moving average is $2.0755.
Tetraphase Pharmaceuticals, Inc. (TTPH) current performance has been indicated by the recent movement in TTPH stock. TTPH has performed 75.20% over the past 30 days, TTPH has performed 0.46% over the past 3 months and TTPH has shown -86.94% over the past year. Tetraphase Pharmaceuticals, Inc. (TTPH) has a 52 week range of $0.5600 to $20.6000. Tetraphase Pharmaceuticals, Inc. (TTPH) is trading 291.07% from its 52 week low and -89.37% from its 52 week high.
TTPH has 9.27M shares outstanding and – shares in the float. Tetraphase Pharmaceuticals, Inc. (TTPH) presently has a market cap of $11.89M and income of $-62.70M. The EPS next quarter for TTPH is -1.28 and projected EPS net year is 60.60%. The market cap of Tetraphase Pharmaceuticals, Inc. (TTPH) at $11.89M represents how many Investors own shares of TTPH and is based off the last price ($2.1900) of TTPH and the amount of shares outstanding (9.27M) with Tetraphase Pharmaceuticals, Inc. (TTPH).
Tetraphase Pharmaceuticals, Inc. (TTPH) has total cash (mrq) of 26.15M, total cash per share (mrq) of 3.6, total debt of TTPH rests at 2.69M and total debt/equity (mrq) is 9.78. Tetraphase Pharmaceuticals, Inc. (TTPH) operational cash flow (ttm) is -54.71M and TTPH leveraged free cash flow (ttm) is -30.64M.
TTPH is trading 46.29% above (bullish) its SMA20, 68.09% above (bullish) its SMA50 and -30.15% below (bearish) its SMA200.
